PK MED is a pioneering French biotech company, privately owned and founded in 2019 in Lyon, France, with the backing of Truffle Capital, a leading European venture capital firm specializing in life sciences.

Built around a dedicated team of passionate and seasoned experts in pharmaceutical sciences, drug delivery, and biomaterials design, PK MED combines innovation and expertise to develop cutting-edge solutions in healthcare.

PK MED specializes in the development of innovative, custom-designed, injectable, and biodegradable micro-implants, leveraging its expertise to address critical healthcare challenges. Our focus lies in advanced drug delivery systems for rheumatology and pioneering cell-homing techniques to enhance the success of bone marrow transplantation.

Driven by a commitment to unmet medical needs, PK MED has built a promising portfolio of early-stage projects targeting key therapeutic areas, including microcrystalline arthritis, osteoarthritis, and hemoglobinopathies

PK MED

Org chart

Teams

Offices